HP
Hendrik Peter Scholl sold $332K of BLTE stock
Hendrik Peter Scholl, Chief Medical Officer of Belite Bio, Inc (BLTE), sold 2,000 shares of BLTE stock worth $332K, per an SEC Form 4 filed Nov 17, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Nov 12, 2026, 5 days before it was made public.
BLTE has moved -11.1% since the trade date, from $169.96 to $151.02 (Nov 19, 2026 close).
- Traded
- Nov 12, 2026
- Disclosed
- Nov 17, 2026
- Filing delay
- 5 days
- Price since
- -11.1%
- Role
- Chief Medical Officer
- Source
- SEC Form 4